Skip to content

PHACE - Prospective Genetic Investigation

PHACE - Prospective Genetic Investigation

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05133245
Acronym
PHACE
Enrollment
50
Registered
2021-11-24
Start date
2021-11-01
Completion date
2026-11-01
Last updated
2025-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PHACE Syndrome

Brief summary

Investigation for potential PHACE syndrome gene.

Detailed description

Subjects with PHACE syndrome diagnosis will undergo a brief physical examination with possible external photographs. Cheek swabs will be sent for genetic analysis. Subjects will be notified of the results.

Interventions

OTHERDiagnostic study only

Diagnostic study only

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* PHACE syndrome diagnosis * Must be willing to have an eye examination * Must be willing to undergo genetic testing

Exclusion criteria

* No PHACE syndrome diagnosis

Design outcomes

Primary

MeasureTime frameDescription
Potential PHACE Gene Identification3 yearsEvaluation for potential PHACE gene

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026